INNOVADERM CRO IS NOW INDERO.

Your Focused Rheumatology CRO

Specialized CRO services for rheumatology studies. We’re all in.

Rheumatology Clinical Research Deserves a Champion

Immune-mediated and autoimmune rheumatic and musculoskeletal diseases (RMDs) are varied and complex; a specialized rheumatology CRO is essential.

Indero serves your clinical trial needs from science to operations and protocols to patient recruitment, ensuring the highest standards of data integrity and reliability. Indero works with: 

  • 20+ rheumatology indications
  • 1,000 investigators
  • 100+ KOLs

Which Rheumatology Indications Can Indero Help With?

As your rheumatology CRO, Indero offers the expertise to support clinical trials for rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), as well as dermatomytositis and psoriatic arthritis (PsA). Our team understands the complexities and unique demands of immune-mediated diseases, bringing depth and precision to every study we support. Here are some of the indications we focus on:
  • Idiopathic inflammatory myopathies (IIM), including dermatomyositis (DM), polymyositis (PM), and juvenile inflammatory myopathies (JIIMs)
  • Radiographic axial spondyloarthritis (r-axSpA), also known as ankylosing spondylitis (AS)
  • Gout
  • Fibromyalgia
  • Behçet’s disease
  • Sjögren’s disease and juvenile Sjögren’s disease
  • Non-radiographic axial spondyloarthritis (nr-axSpA)
  • Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAVs)
  • Polymyalgia rheumatica
  • Giant cell arteritis
  • IgG4-related disease (IgG4-RD)

Focused Expertise in Some Key Indications

Indications

Systemic lupus erythematosus (SLE)

Systemic sclerosis (scleroderma, SSc)

Spondyloarthritis spectrum

Specificities

SLE trials face unique complexities due to the disease’s heterogeneity, different treatment paradigms across the globe, uncontrolled use of background glucocorticoids, and use of convoluted composite endpoints that capture organ-specific responses and overall disease activity

Systemic sclerosis is a rare autoimmune disease characterized by immune imbalance, fibrosis, and vascular abnormalities, making endpoint selection and recruitment particularly challenging

The spondyloarthritis spectrum encompasses a range of diseases sharing common inflammatory pathways but requiring distinct endpoints and trial designs

Key Challenges

  • High variability in flare frequency and variable flare definitions
  • Background therapy not properly controlled
  • The need to measure both clinical (e.g., joint involvement, skin rashes) and serological (e.g., anti-dsDNA, complement levels) responses
  • High placebo response rates, making it difficult to demonstrate superiority of investigational therapies
  • Complexity and overlapping disease activity scores (SLEDAI-2K, BILAG-2004, joint counts, and CLASI) that create data mismatch due to their design nature and variable definitions of lupus manifestations
  • Reliance on imaging-based endpoints (MRI, X-ray) for spinal and sacroiliac joint inflammation
  • The need to measure both axial (spinal) and peripheral (joint, enthesitis) involvement
  • Capturing dermatologic endpoints in PsA, such as PASI for skin lesions
  • Common extra-articular manifestations such as emergent uveitis and gastrointestinal inflammatory conditions (inflammatory bowel disease-associated arthropathy)

Indero Approach

Our team employs validated composite endpoints like SLE Responder Index (SRI), British Isles Lupus Assessment Group-based Composite Lupus Assessment (BICLA), and organ-specific indices such as EULAR/ERA-EDTA renal response, and CLASI skin score   We partner with specialized lupus centers to accelerate recruitment of well-characterized patients Centralized adjudication of disease activity at entry and during study duration by expert “lupus trialists” ensures consistent assessment of disease activity status across sites, enhancing data reliability, detection of efficacy signals, and controlling placebo response rates.
We are familiar with the standardized imaging techniques (e.g., HRCT for lung fibrosis) and pulmonary function testing to capture subtle changes in disease progression

Our trial network, focused on rheumatology sites, ensures access to experienced investigators and accelerates recruitment

Rigorous training of site staff in mRSS (hands-on workshops with real patients and training certification) and lung function assessment ensures consistent, high-quality data collection
We utilize centralized imaging reviews with radiologists trained in SpA standardized scoring systems (e.g., SPARCC, mSASSS)

Our dual expertise in dermatology and rheumatology ensures consistent staff training on assessment of both musculoskeletal and skin outcomes in PsA

Clear protocol recommendations on how to manage emergent extra-articular manifestations (e.g., uveitis, inflammatory bowel disease), clear derivation channels to relevant specialists for assessments, and clear definitions of rescue therapy alternatives and IMP discontinuation rules

Platform trial designs enable sponsors to evaluate multiple mechanisms of actions, reducing costs and increasing trial efficiency

Our Scientific Rheumatology Capabilities

We ensure precise patient selection and reliable efficacy data through advanced clinical phenotyping and imaging. Our expert team excels in managing eligibility criteria and complex scoring systems, adhering to the latest standards from major scientific authorities.

Rheumatology CRO Services

Indero’s full-service model supports rheumatology studies from start to finish. With scientific and medical rigor, operational efficiency, and specialized clinical development, we prioritize data quality at every step. Our tailored insights and quality data ensure on-time, effective study execution.

Why Choose Indero for Rheumatology Clinical Research?

Indero is a specialized dermatology and rheumatology CRO with deep expertise, bringing more than 25 years of experience in clinical trial delivery. Our full-service approach, from protocol design and patient recruitment to monitoring and biometrics, prioritizes data quality in all processes and training programs. This commitment equips biotech and pharmaceutical sponsors with the clinical rigor and medical expertise to drive rheumatology studies to success. Our operations span the world, with capabilities in North America, Europe, Latin America, and Asia Pacific. Our connections include 3,100+ investigators, making us a trusted partner for efficient and effective rheumatology trials at a global scale.

“…From the initial synopsis development to the final stages of study conduct, the synergy between our teams was palpable and was underpinned by Indero’s strong relationships with sites, investigators, and KOLs…”

Snehal Naik, PhD

Senior Vice President, Clinical Development

Rheumatology CROs vs Generalist CROs

If your partner only has general experience, they may not be able to handle the nuances that come with rheumatology research. Our checklist shares the questions you should ask to determine your CRO’s readiness and explains how a specialist rheumatology CRO stands out. Areas where generalist CROs struggle in rheumatology research may include:
  • Scientific and medical expertise
  • Outcome assessment and data integrity
  • Risk management and trial governance
  • Operational and scientific infrastructure
Download the checklist for more details.

Achieving a Low 4% Discontinuation Rate

in a Systemic Sclerosis Trial

Indero successfully navigated the complexities of a study on systemic sclerosis (SSc), demonstrating strategies that enhanced subject retention and streamlined recruitment.

Challenges

  • Diverse Patient Demographics: Enrolled 49 subjects across various geographies due to the condition’s rarity.
  • Recruitment Appeal: The lack of treatment options in the study made participation less attractive.
  • Logistical Coordination: Coordinating transport and clinic visits for distant subjects posed significant challenges.

Strategies

  • Timely Recruitment: Completed recruitment on schedule without advertisements, despite local academic site complexities.
  • Low Discontinuation Rate: Achieved a remarkable 4% subject discontinuation rate, reflecting strong engagement.
  • Effective Coordination: Managed logistical complexities to ensure seamless subject transportation to the clinic.

Our Rheumatology Insights

Post

Nine Strategies to Address High Placebo-Arm Response in Systemic Lupus Erythematosus (SLE) Clinical Trials

Post

Eureka! Insights from EULAR 2026, Rheumatology’s Euro-Bonanza

Post

Building Momentum in Clinical Trial Start‑Up

Dr. Scott Guenthner

The Dermatology Center of Indiana and the Indiana Clinical Trials Center

“Outstanding level of support.

Indero has truly been a reliable CRO partner to us over the years and has continuously offered an outstanding level of support to our recruitment activities.”

Our Rheumatologists

Introducing Indero’s rheumatologists. They are an integral part of the rheumatology team, bringing more than 70 years of combined experience in the field, and are supported by our comprehensive operational CRO team, ready to support you at every stage.

Frequently Asked Questions

What is a rheumatology CRO?

A rheumatology CRO specializes in and understands the caveats and challenges of rheumatology diseases and target populations. They combine medical, scientific, and clinical expertise in rheumatology to ensure successful trial management and execution.

When selecting a rheumatology CRO, consider these key factors:

  • Expertise: Look for a CRO with specialized medical, scientific, and clinical knowledge and experience in rheumatology to ensure the trial’s relevance and scientific rigor.
  • Regulatory Knowledge: Ensure the CRO adopts a strategic approach that extends beyond regulatory submissions, incorporating rheumatology endpoints, medical and scientific writing services, and support for regulatory agency meetings. This comprehensive understanding of regulatory requirements and the compliance process aids in effectively navigating potential challenges.
  • Infrastructure: Evaluate their relationships with rheumatology research sites, focusing on their ability to select and assess sites based on their performance, geographical reach, and patient recruitment capabilities, which are essential for timely and efficient study execution.
  • Quality: Choose a CRO that lives and breathes rheumatology data quality. They should have robust ties to top-enrolling sites and a core focus on science and innovation to safeguard subject safety and data integrity. They should also proactively identify and mitigate risks throughout the study.

A specialized CRO enhances your trial by providing medical, scientific, and clinical rheumatology expertise in addition to tailored patient engagement strategies and streamlined operations. Their deep understanding of regulatory requirements and established rheumatology-specific networks can lead to more efficient trial execution and improved patient outcomes, ultimately advancing treatment options in this critical field.

Wherever
You’re Going,
We’re all in.

Need help with your next study? We want to learn more. Fill out the form on the right and one of our experts will be in touch.

Fields marked with * are required.

PROJECT MANAGEMENT

We orchestrate all study activities and deliverables, including the site selection process, budget and contract negotiations, patient engagement, and recruitment enrollment projections, all while respecting your study timelines.

Patient Recruitment

Looking for a partner for patient recruitment and advertising? Our dedicated patient recruitment and advertising team integrates with clinical trial sponsors and study teams to tailor recruitment strategies, customize central ad campaigns, develop advertising creative, and continuously track and adapt recruitment goals. Our patient-centric approach is enhanced by Clinago, our technology-enabled recruitment service.

Clinical Monitoring

Leveraging an average of 15+ years of industry experience, our seasoned clinical operations team offers both adaptive monitoring services (on-site and remote) and centralized monitoring services. All of our team members undergo extensive dermatology training. We ensure compliance with rheumatology study protocols, sound clinical practices, and applicable regulations. Our team is skilled in identifying data inconsistencies, performing trend analysis, and detecting patterns or outliers. Additionally, we offer tailored training programs for sites in rheumatology to ensure they are well-equipped with the latest knowledge and best practices.

Medical Monitoring

We provide clinical oversight to protect subject safety and maintain data integrity. Our responsive medical monitors work directly with sites to address issues quickly, ensuring adherence and reliable data that keep your rheumatology trials on track.

Pharmacovigilance

Our pharmacovigilance services span various therapeutic areas and track, assess, and report safety data to manage your trial risks effectively. Through continuous monitoring and regulatory reporting, we ensure subject safety, providing you with the confidence and clarity you need.

Biostatistics & Data Management

Our extensive biometric services cater to all your biostatistics and data management requirements, meticulously aligned with your rheumatology study goals and other medical fields. We offer a range of services, including adaptive design, strategic statistical consulting, sample size and power calculations, database design, medical coding, and thorough data validation, review, and cleaning.

Study Design & Protocol Writing

With deep expertise and vast operational experience, we can help you design an innovative and efficient patient-centric rheumatology study that meets your scientific objectives while optimizing your financial investment. We engage with key opinion leaders to shape trial designs leading to improved study site engagement.

Clinical Development & Regulatory Consulting

We can help you navigate the global regulatory landscape and provide clinical development consulting, covering end-to-end needs, including drug and device submissions, medical and scientific writing, clinical pre-feasibility, scientific support, and even meeting with regulatory agencies.

Site Selection & Management

Our long-standing relationships with key opinion leaders and highly performing sites result in optimized start-up processes that deliver strong results in the least amount of time. As part of our site evaluation, our team utilizes past performance metrics, recruitment projections based on the competitive landscape, and detailed feasibility surveys to determine a site’s capabilities and interest in a study.

Medical Writing

We provide expert scientific and regulatory writing services, delivering high-quality clinical study protocols designed and drafted by our team of clinical scientists, rheumatologists, and operations specialists, with contributions from clinical study coordinators, all tailored to your requirements and specifications.

Quality Assurance

Our quality assurance service ensures the highest standards of compliance and data integrity. We implement rigorous quality control processes to identify and mitigate risks early.